For example, the political debates around universal health care or changes in national health insurance coverage are important concerns to people with diabetes, as these changes often impact the price and availability of insulin and glucose-monitoring technologies (eg, the #WeAreNotWaiting advocacy and awareness campaign [13]). This evidence concerns the gene INS and diabetes mellitus.